Searched for
SII CHIEF
ET Awards: Groww CEO Lalit Keshre on building India’s largest stock broking platform and future growth plansGroww, led by Lalit Keshre, has become India's top stock broking platform. The company recently saw its market capitalization surge signifi...- Oxford-Serum malaria vaccine wins WHO's recommendationThe R21/Matrix-M malaria vaccine is an easily deployable vaccine that can be manufactured at mass scale at a modest cost, enabling as many ...
- Malaria vaccine by Oxford & Serum Institute of India gets WHO recommendationThe University of Oxford and Serum Institute of India (SII) have developed a malaria vaccine, which has been recommended for use by the Wor...
- SII is working on an Omicron-specific vaccine, may launch it by the end of this year: ReportSII Chief Executive Officer Adar Poonawalla told NDTV that the vaccine is being developed in collaboration with Novavax. Poonawalla further...
- Vaccine giant Serum Institute of India plans African plant in global expansionSII Chief Executive Adar Poonawalla said he was meeting some African officials in Davos to discuss his plans. Asked about possible investme...
- Serum likely to start vaccine supplies to Covax this weekIn an interview to ET in October, SII chief executive Adar Poonawalla said that large exports would start from January, whereas small expor...
- Covovax nod expected by January, data to be submitted soon, says SII ChiefThe drug regulator had earlier asked the company - which had applied for emergency use authorisation (SII) for Covovax in August - to submi...
- Biocon unit plans 15% stake sale to Serum Institute for access to vaccinesThe deal with Serum Institute Life Sciences values Biocon Biologics at about $4.9 billion and will solely focus on COVID-19 vaccines in the...
- Serum Institute confident of European drug regulator nod for Covishield in a monthPoonawalla said SII has applied to the European Medicines Agency (EMA) through AstraZeneca. "The process has to take its time. An approval ...
- Covishield price for states slashed from Rs 400 to Rs 300 per dose: Adar PoonawallaThe SII, which is India's largest vaccine manufacturer, had earlier priced Covishield at Rs 400 per dose for the state governments and Rs 6...
- What price your vaccine? SII says India private price among cheapestBharat Biotech on Saturday said it has priced Covaxin at ₹1,200 ($16) for the private market, while the Russian Development Investment Fund...
- COVAX says India's Serum Institute bound to supply virus vaccinesIndia, where infections have surged to 13.06 million, suspended all major exports of vaccines last month to fill demand at home, forcing th...
- SII fails to deliver, New Delhi’s vaccine diplomacy hits hurdleSII chief Adar Poonawalla wrote to Brazil, Morocco and Saudi Arabia that there would be an unspecified delay in sending vaccines that have ...
- India's Serum Institute delays vaccines for private sale in Bangladesh; focus on state campaignsAstraZeneca has been embroiled in a dispute in Europe after it said it would have to cut supplies of its vaccine there in the first quarter.
- Saudi Arabia to get three million AstraZeneca shots in a week from India's Serum InstituteSII, the world's biggest vaccine manufacturer, has partnered with AstraZeneca, the Gates Foundation and the Gavi vaccine alliance to make u...
- Fire at Serum Institute of India: Production of BCG, Rotavirus vaccines impactedApart from financial loss, the mishap will impact the production of BCG and Rotavirus vaccines, the company said in a statement.
- Serum pegs losses due to fire at over Rs 1,000 crore; Maha CM says probe in blaze onThe chief minister visited the SII on Friday to take stock of the damages. He later addressed a press conference, where Adar Poonawalla, Ch...
- 5 dead in Serum Institute fire; Covishield facility unaffectedThe building where the fire broke out is part of the under-construction site of the Serum facility and is one km from the Covishield manufa...
- Centre may purchase 300-400 million Covishield doses by July 2021: Adar PoonawallaSII has partnered with global pharma giant AstraZeneca and Oxford University for the vaccine candidate 'Covidshield'. "As of now we don't h...
- Serum says made 40 mn doses of AstraZeneca's COVID vaccine, to make Novavax shot soonSerum said it has enrolled 1,600 participants in India for late-stage trials of AstraZeneca's candidate, and also plans to seek regulatory ...
Load More
